Circulating visfatin concentrations in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis

Circulating visfatin concentrations in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis

ObjectiveThe current study was designed with the aim of conducting a systematic review and meta-analysis to determine the circulating levels of visfatin in patients with chronic obstructive pulmonary disease (COPD) compared to healthy individuals.MethodsUntil March 2024, we searched the Web of Scien...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Nahid Aboutaleb, Alireza Moradi, Hamzeh Mirshekari Jahangiri, Mohammad Reza Aslani
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Frontiers Media S.A. 2025-01-01
Sraith:	Frontiers in Medicine
Ábhair:	visfatin meta-analysis COPD IL-6 BMI
Rochtain ar líne:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1432025/full

Míreanna comhchosúla

Serum levels of visfatin, sirtuin-1, and interleukin-6 in stable and acute exacerbation of chronic obstructive pulmonary disease
de réir: Hassan Ghobadi, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin
de réir: Anna Maria Cybulska, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Circulating endothelial cells and serum visfatin are indicators of cardiovascular disease risk in psoriasis patients
de réir: Lamia Elgarhy, et al.
Foilsithe / Cruthaithe: (2016-03-01)

Tissue Expression of Visfatin in Psoriatic Patients
de réir: Abd El-Aziz El-Rifaie, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Breastfeeding effects on visfatin levels in postpartum women
de réir: Ching-Ju Shen, et al.
Foilsithe / Cruthaithe: (2015-06-01)

CIRCULATING VISFATIN LEVEL AND ITS ASSOCIATION WITH LIPID BIOMARKERS IN PREGNANCY INDUCED HYPERTENSION
de réir: Asmat Shaheen, et al.
Foilsithe / Cruthaithe: (2017-07-01)

The Role of Visfatin, Leptin, and IL-18 in Polycystic Ovarian Syndrome Patients
de réir: Sukayna H. Rashed, et al.
Foilsithe / Cruthaithe: (2024-12-01)

The influence of age on the responses of serum visfatin and insulin resistance to a single session of endurance exercise
de réir: هیوا رحمانی, et al.
Foilsithe / Cruthaithe: (2013-04-01)

Acute Phase Serum Leptin, Adiponectin, Interleukin-6, and Visfatin Are Altered in Chinese Children With Febrile Seizures: A Cross-Sectional Study
de réir: Jie-ru Chen, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Effect of Non-surgical Periodontal Therapy on Serum and Salivary Concentrations of Visfatin in Patients with Chronic Periodontitis
de réir: Nader Abolfazli, et al.
Foilsithe / Cruthaithe: (2015-03-01)

Association between visfatin and periodontitis: a systematic review and meta-analysis
de réir: Yaoqin Li, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Research progress on the role and mechanism of visfatin in sepsis-related organ injury
de réir: KUANG Zhong-shen, CONG Zhu-kai, WU Chang-yi, YANG Ning, ZONG Ya-nan, GUO Xiang-yang
Foilsithe / Cruthaithe: (2022-08-01)

Lipid profiles and serum visfatin concentrations in patients with type II diabetes in comparison with healthy controls
de réir: Hossein Hajianfar, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Trimetazidine with an adjuvant therapy to normalize the circulating visfatin concentration: Future perspective and mechanistic strategies
de réir: G. Uma Maheswari, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Changes in concentration of visfatin during four weeks of inpatient treatment of alcohol dependent males
de réir: Damian Czarnecki, et al.
Foilsithe / Cruthaithe: (2015-09-01)

Salivary visfatin concentrations in patients with chronic periodontitis: An analysis before and after periodontal therapy
de réir: Anudeep Mopidevi, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Periodontitis is associated with the increased levels of visfatin: a meta-analysis
de réir: Junfei Zhu, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Evaluation of salivary levels of visfatin in obese patients with chronic periodontitis
de réir: Vivek Kumar, et al.
Foilsithe / Cruthaithe: (2019-01-01)

The Activity of Sirtuin 1 in MCF-7 Breast Cancer Cell Line: The Effects of Visfatin
de réir: kiarash behrouzfar, et al.
Foilsithe / Cruthaithe: (2015-11-01)

Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes
de réir: Soheila Asadi, et al.
Foilsithe / Cruthaithe: (2015-06-01)

Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric measurements indices
de réir: M Davutoglu, et al.
Foilsithe / Cruthaithe: (2009-01-01)

Effects of Angiotensin Receptor Blockers on Apelin and Visfatin in Hypertension
de réir: Mina Mohammed, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Visfatin and its Role in Breast Cancer
de réir: Robab Sheikhpour
Foilsithe / Cruthaithe: (2017-09-01)

An Enflammatory Marker in Chronic Renal Failure Patients: Visfatin
de réir: Yavuz Ayar, et al.
Foilsithe / Cruthaithe: (2010-12-01)

The Diagnostic Value of Irisin and Visfatin in Experimental Testicular Torsion
de réir: Fatma Saraç, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Retinol-Binding Protein 4 and Visfatin Levels in Patients with Periodontitis and Obesity/Overweight: A Systematic Review and Meta-Analysis
de réir: Yuwei Zhang, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Serum Adipocytokines (Visfatin and Resistin): New Biomarkers of Breast Carcinogenesis
de réir: Sanaa A. El-Benhawy, et al.
Foilsithe / Cruthaithe: (2015-10-01)

Visfatin levels in non-obese, obese, and insulin resistant adolescents
de réir: Indra Ihsan, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Serum levels of adiponectin and visfatin in patients with lichen planus: a case-controlled study
de réir: Sahar A Ismail, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Comparative evaluation of serum apelin, visfatin, and lipid levels in overweight hypertensive patients on enalapril versus telmisartan therapy
de réir: Mina Khalid MOHAMMED, et al.
Foilsithe / Cruthaithe: (2024-09-01)

The effect of n-fatty acid (omega 3) on serum visfatin concentration in patients with type2 diabetes
de réir: MohammadJavad Hoseinzadeh Attar, et al.
Foilsithe / Cruthaithe: (2012-04-01)

Correlation of salivary visfatin levels in obese and NON-OBESE population with periodontal status
de réir: Arvina Rajasekar
Foilsithe / Cruthaithe: (2023-01-01)

Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice
de réir: Young Sun Kang, et al.
Foilsithe / Cruthaithe: (2016-05-01)

Novel 6-bp Deletion Mutation in visfatin Gene and Its Associations with Birth Weight and Bodyweight in Chinese Cattle
de réir: Mou WANG, et al.
Foilsithe / Cruthaithe: (2012-08-01)

VISFATIN LEVEL DISTURBANCES IN PERIPHERAL BLOOD OF PATIENTS WITH DIABETIC NEPHROPATHY
de réir: I.I. Topchii, et al.
Foilsithe / Cruthaithe: (2014-12-01)

Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
de réir: Radhika Gaddipati, et al.
Foilsithe / Cruthaithe: (2010-07-01)

Comparative Effects of Candesartan Versus Enalapril on Apelin, Visfatin, and Lipid Levels in Non-obese Hypertensive Patients
de réir: Yaseen K. JUMAAH, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Comparison of Serum Visfatin Levels in Post-Menopausal Pakistani Women with and Without Breast Carcinoma
de réir: Lubna Gohar, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Serum visfatin in chronic renal failure patients on maintenance hemodialysis: A correlation study
de réir: Abdel Wahab M Lotfy, et al.
Foilsithe / Cruthaithe: (2013-01-01)

The relation of visfatin with nausea and vomiting in the pregnancy
de réir: Farnaz Jahani, et al.
Foilsithe / Cruthaithe: (2020-01-01)